A case report on topical steroids causing infantile iatrogenic cushing syndrome
Keywords:
topical steroids, infantile iatrogenic, syndrome, case reportAbstract
Cushing Syndrome is characterised by raised levels of Glucocorticoids in free plasma. It is caused because of excess endogenous release of steroids or excess usage of exogenous steroids. The common form Cushing syndrome present in children is Iatrogenic Cushing syndrome. It is either due to excessive administration of parenteral or oral preparations of steroids which are used in treatment of pulmonary, renal, haematological and autoimmune diseases. Topical steroids rarely causes Cushing syndrome. In our case report, We will describe about a four month old girl child who developed Cushing syndrome ( Iatrogenic ) because of prolonged and excessive use of Topical preparations steroids Namely clobetasol for treatment of napkin ( diaper ) dermatitis.
Downloads
References
R. R. Lonser, L. Nieman, and E. H. Oldfield, “Cushing’s disease: pathobiology, diagnosis, and management,” Journal of Neurosurgery, vol. 126, no. 2, pp. 404–417, 2017.
C. A. Stratakis, “Cushing syndrome in pediatrics,” Endocri- nology and Metabolism Clinics of North America, vol. 41, no. 4, pp. 793–803, 2012.
C. A. Stratakis, “Diagnosis and clinical genetics of Cushing syndrome in pediatrics,” Endocrinology and Metabolism Clinics of North America, vol. 45, no. 2, pp. 311–328, 2016.
J. W. Findling and H. Raff, “Cushing’s syndrome: important issues in diagnosis and management,” The Journal of Clinical Endocrinology & Metabolism, vol. 91, no. 10, pp. 3746–3753, 2006.
L. K. Nieman, “Recent updates on the diagnosis and man- agement of Cushing’s syndrome,” Endocrinology and Meta- bolism, vol. 33, no. 2, pp. 139–146, 2018.
K. J. Shetty and R. Spurgeon, Cushing’s Syndrome: Challenges in Diagnosis and Management. Chapter 65, The Association of Physicians of India, Mumbai, India, 2013.
R. M. Paragliola, G. Papi, A. Pontecorvi, and S. M. Corsello, “Treatment with synthetic glucocorticoids and the hypo- thalamus-pituitary-adrenal axis,” International Journal of Molecular Sciences, vol. 18, no. 10, 2017.
S.Semiz,Y.I.Balcı,S ̧.Ergin,M.Candemir,andA.Polat,“Two cases of Cushing’s syndrome due to overuse of topical steroid in the diaper area1,” Pediatric Dermatology, vol. 25, no. 5, pp. 544–547, 2008.
E. M. Abma, R. Blanken, and L. J. De Heide, “Cushing’s syndrome caused by topical steroid therapy for psoriasis,” The Netherlands Journal of Medicine, vol. 60, no. 3, pp. 148–150, 2002.
S. Decani, V. Federighi, E. Baruzzi, A. Sardella, and G. Lodi, “Iatrogenic Cushing’s syndrome and topical steroid therapy: case series and review of the literature,” Journal of Derma- tological Treatment, vol. 25, no. 6, pp. 495–500, 2014.
B. Sahip, M. Celik, S. Ayturk et al., “Iatrogenic Cushing’s syndrome after topical steroid therapy for psoriasis,” Indian Journal of Dermatology, vol. 61, no. 1, p. 120, 2016.
T. Tempark, V. Phatarakijnirund, S. Chatproedprai, S. Watcharasindhu, V. Supornsilchai, and S. Wananukul, “Exogenous Cushing’s syndrome due to topical corticosteroid application: case report and review literature,” Endocrine, vol. 38, no. 3, pp. 328–334, 2010.
A. Gu ̈ven, S. Karadeniz, O. Aydin, M. Akbalik, and M. Aydin, “Fatal disseminated cytomegalovirus infection in an infant with Cushing’s syndrome caused by topical steroid,” Hormone Research in Paediatrics, vol. 64, no. 1, pp. 35–38, 2005.
J. D. Ference and A. R. Last, “Choosing topical corticoste- roids,” American Family Physician, vol. 79, no. 2, pp. 135–40, 2009.
Z. Siklar, I. Bostanci, O. Atli, and Y. Dallar, “An infantile Cushing syndrome due to misuse of topical steroid,” Pediatric Dermatology, vol. 21, no. 5, pp. 561–563, 2004.
S. Borresen, M. Klose, A. Rasmussen, and U. Feldt-Ras- mussen, “Adrenal insufficiency caused by locally applied glucocorticoids-myth or fact?,” Current Medicinal Chemistry, vol. 22, no. 23, pp. 2801–2809, 2015.
M. Turpeinen, O. P. Salo, and S. Leisti, “Effect of percutaneous absorption of hydrocortisone on adrenocortical re- sponsiveness in infants with severe skin disease,” British Journal of Dermatology, vol. 115, no. 4, pp. 475–484, 1986.
C. Carrozza, S. M. Corsello, R. M. Paragliola et al., “Clinical accuracy of midnight salivary cortisol measured by automated electrochemiluminescence immunoassay method in Cush- ing’s syndrome,” Annals of Clinical Biochemistry, vol. 47, no. 3, pp. 228–232, 2010.
Published
How to Cite
Issue
Section
Copyright (c) 2022 International journal of health sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the International Journal of Health Sciences (IJHS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.
Articles published in IJHS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
This copyright notice applies to articles published in IJHS volumes 4 onwards. Please read about the copyright notices for previous volumes under Journal History.
